Maven Securities LTD Kura Oncology, Inc. Transaction History

Maven Securities LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$11.78 - $16.98 $403,983 - $582,312	-34,294 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$12.22 - $19.57 $419,072 - $671,133	34,294 New	34,294 $480,000
Q1 2021 May 17, 2021	SELL	$24.75 - $39.14 $346,500 - $547,960	-14,000 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$29.0 - $41.62 $406,000 - $582,680	14,000 New	14,000 $476,000

174

80.4M

914K

120K

Ticker KURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,893,000
Market Cap $1.34B
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...

Get notified when there are updates to the investment portfolio of Maven Securities LTD, based on Form 13F filings with the SEC.

Stay updated on Maven Securities LTD with notifications on news.